Wells Fargo’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $338K | Buy |
|
|||||
|
2025
Q1 | $271K | Buy |
|
|||||
|
2024
Q4 | $179K | Buy |
|
|||||
|
2024
Q3 | $187K | Buy |
|
|||||
|
2024
Q2 | $268K | Buy |
|
|||||
|
2024
Q1 | $325K | Buy |
|
|||||
|
2023
Q4 | $345K | Sell |
|
|||||
|
2023
Q3 | $1.81M | Buy |
|
|||||
|
2023
Q2 | $2.56M | Buy |
|
|||||
|
2023
Q1 | $2.15M | Buy |
|
|||||
|
2022
Q4 | $371K | Sell |
|
|||||
|
2022
Q3 | $485K | Buy |
|
|||||
|
2022
Q2 | $83K | Buy |
|
|||||
|
2022
Q1 | $52K | Buy |
|
|||||
|
2021
Q4 | $53K | Sell |
|
|||||
|
2021
Q3 | $3.29M | Sell |
|
|||||
|
2021
Q2 | $7.06M | Buy |
|
|||||
|
2021
Q1 | $7.75M | Sell |
|
|||||
|
2020
Q4 | $9.15M | Sell |
|
|||||
|
2020
Q3 | $8.81M | Buy |
|
|||||
|
2020
Q2 | $5.38M | Buy |
|
|||||
|
2020
Q1 | $3.32M | Buy |
|
|||||
|
2019
Q4 | $5.66M | Sell |
|
|||||
|
2019
Q3 | $61.7M | Buy |
|
|||||
|
2019
Q2 | $71.8M | Buy |
|
|||||
|
2019
Q1 | $59.1M | Buy |
|
|||||
|
2018
Q4 | $29.8M | Sell |
|
|||||
|
2018
Q3 | $54.9M | Buy |
|
|||||
|
2018
Q2 | $43.7M | Buy |
|
|||||
|
2018
Q1 | $26.8M | Buy |
|
|||||
|
2017
Q4 | $5.14M | Sell |
|
|||||
|
2017
Q3 | $6.48M | Buy |
|
|||||
|
2017
Q2 | $5.95M | Buy |
|
|||||
|
2017
Q1 | $2.39M | Sell |
|
|||||
|
2016
Q4 | $1.91M | Buy |
|
|||||
|
2016
Q3 | $982K | Sell |
|
|||||
|
2016
Q2 | $822K | Buy |
|
|||||
|
2016
Q1 | $814K | Buy |
|
|||||
|
2015
Q4 | $1.45M | Buy |
|
|||||
|
2015
Q3 | $646K | Buy |
|
|||||
|
2015
Q2 | $1.03M | Buy |
|
|||||
|
2015
Q1 | $82K | Buy |
|
|||||
|
2014
Q4 | $10K | Buy |
|